Question · Q4 2025
Peter Warendorf asked for clarification on how Progyny bridges the gap between mid-to-high single-digit membership growth and low double-digit revenue growth, seeking insights into contributions from utilization, upsells, and new products. Warendorf also inquired if there were any unusual trends in treatment mix given the current macro uncertainty.
Answer
Mark Livingston (CFO) explained that the 11% revenue growth at the midpoint is driven by increases in utilizers, ART cycles, and a rate element. Pete Anevski (CEO) added that the replacement of lower-utilizing lives with higher-utilizing ones also contributes to this bridge. Pete Anevski (CEO) stated there was nothing unusual to report regarding treatment mix.
Ask follow-up questions
Fintool can predict
PGNY's earnings beat/miss a week before the call